Rheumatology NewsMedical marijuana’s ‘Catch-22’: Federal limits on research hinder patients’ reliefApril 12, 2018Pain
Rheumatology NewsMost physicians support Medicaid work requirementsApril 11, 2018Business of Medicine
Rheumatology NewsPatient advocacy groups take in millions from drugmakers. Is there a payback?April 6, 2018Business of Medicine
Rheumatology NewsCMS finalizes measures to help combat opioid crisisApril 5, 2018PainBusiness of Medicine
Rheumatology NewsOpen enrollment 2018: Plan selections down slightlyApril 5, 2018Business of Medicine
Rheumatology NewsMedicare Part D plans get more flexibility to make midyear changesApril 4, 2018Business of Medicine
Rheumatology News2018 FNIH Lurie Prize awarded for DNA immune response discoveryApril 4, 2018Rheumatoid Arthritis
Rheumatology NewsPreprint publishing challenges the status quo in medicineMarch 30, 2018Business of Medicine
Rheumatology NewsThousands mistakenly enrolled during state’s Medicaid expansion, feds findMarch 28, 2018Business of Medicine
Rheumatology NewsCancer groups offer guidance on musculoskeletal adverse events related to checkpoint inhibitorsMarch 27, 2018Rheumatoid ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsDrug pricing proposals raise red flags with specialistsMarch 26, 2018Business of Medicine
